Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 28:10.1097/FJC.0000000000001688.
doi: 10.1097/FJC.0000000000001688. Online ahead of print.

The 5-HT7 receptor contributes to increased hindquarter blood flow caused by skeletal muscle contraction

Affiliations

The 5-HT7 receptor contributes to increased hindquarter blood flow caused by skeletal muscle contraction

Teresa Krieger-Burke et al. J Cardiovasc Pharmacol. .

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) at low plasma concentrations reduces blood pressure and dilates some skeletal muscle arterioles in the rat. We hypothesized that the 5-HT7 receptor is essential for both 5-HT-induced changes in blood pressure and skeletal muscle arteriolar function. Male 5-HT7 receptor knock out (KO) rats under isoflurane anesthesia had a higher resting hindquarter vascular resistance [HQVR; mm Hg/ml/min; KO (16.0+2.0) vs WT (10.8+0.6.0), p = 0.04]; this was not observed in females. The reduction in blood pressure and HQVR caused by intravenous infusion of 5-HT (25 μg/kg/min) was attenuated (∼56%) in male and female KO rats vs WT. Left anterior descending (LAD) coronary arterial ligation was used to create a model of impaired hindquarter perfusion and exercise intolerance. The goal was to determine whether heart failure associated skeletal muscle blood flow abnormalities were affected by loss of a functioning 5-HT7 receptor in skeletal muscle vasculature. Transdermal neuromuscular electrical stimulation (NMES) was used to mimic exercise induced contraction of skeletal muscle and increase blood flow in the hindquarters (HQ). Male (M) and female (F) 5-HT7 receptor KO rats had a profoundly reduced ability to increase HQ flow during NMES vs WT (% increase from basal; M WT = 118.0+18.0 vs KO=14.6+7.1%; F WT= 101.0+12.0 vs KO = 7.6+6.0%), observed in sham and LAD rats. In a naive cohort of 5-HT7 WT and KO rats, NMES-induced increases in HQ flow did not occur in 5-HT7 receptor KO rats. The NMES-induced increase in HQ flow was also abolished in the presence of the 5-HT7 receptor antagonist SB269970 in normal Sprague-Dawley rats. Lectin visualization of gastrocnemius muscle microvasculature indicateded that the elevated HQVR at rest in male 5-HT7 receptor KO rats was not due to a reduced microvascular density vs the WT. We conclude that 5-HT acting at least in part via the 5-HT7 receptor may have a larger role in (patho)physiological regulation of the circulation than has been heretofore appreciated.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None Declared.

References

    1. Diaz J, Ni W, King A, Fink GD, Watts SW. 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther. 2008;325:1031–1038. - PubMed
    1. Davis RP, Pattison J, Thompson JM, Tiniakov R, Scrogin KE, Watts SW. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved. BMC Pharmacol. 2012;12:4 doi: 10.11186/1471-2210-12-4. - DOI - PMC - PubMed
    1. Jackson WF, Daci A, Thompson JM, Fink GD, Watts SW. 5-HT7 receptors mediate dilation of rat cremaster muscle arterioltes in vivo. Microcirculation. 2023:e12808. doi: 10.111/micc.12808. - DOI - PMC - PubMed
    1. Watts SW, Darios ES, Seitz BM, Thompson JM. 5-HT is a potent relaxant in rat superior mesenteric veins. Pharmacol Res Perspect. 2015;3:e00103. doi: 10.1002/prp2.103. - DOI - PMC - PubMed
    1. Seitz BM, Krieger-Burke T, Fink GD, Watts SW. Serial measurements of splanchnic vein diameters in rats using high frequency ultrasound. Frontiers in Pharmacology; Experimental Pharmacology and Drug Discovery. 2016; 10.3389/fphar.2016.00116. - DOI - PMC - PubMed

LinkOut - more resources